A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver Function

Locations

Slovakia

Start date

13/05/2026

Identifiers

Trial ID NN9490-8156,
NCT number NCT07587710,
Eudract number Not Available

Summary

The study is testing a new study medicine to treat people with overweight/obesity and type 2 diabetes. The aim of this study is to see if it is safe and to find out how it works in people with reduced liver function and people with normal liver function.

Trial Overview:

Condition

Overweight

Obesity

Treatment

DRUG: NNC0487-0111

Study type

INTERVENTIONAL

Trial duration

May 13 2026 - Dec 01 2027

Participants

Phase

Are you eligible?

Gender

Male and female

Age

18 to 80 years old

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.